SZ137 Pill - white oval, 22mm
Pill with imprint SZ137 is White, Oval and has been identified as Amoxicillin and Clavulanate Potassium Extended Release 1000 mg / 62.5 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Amoxicillin/clavulanate is used in the treatment of Bacterial Infection; Bronchitis; Aspiration Pneumonia; Bronchiectasis; Febrile Neutropenia and belongs to the drug class penicillins/beta-lactamase inhibitors. There is no proven risk in humans during pregnancy. Amoxicillin/clavulanate 1000 mg / 62.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ137


Amoxicillin and Clavulanate Potassium Extended Release
- Imprint
- SZ137
- Strength
- 1000 mg / 62.5 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Penicillins/beta-lactamase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00781-1943
- Inactive Ingredients
-
microcrystalline cellulose,
citric acid monohydrate,
hypromelloses,
magnesium stearate,
polyethylene glycol,
silicon dioxide,
sodium starch glycolate type A potato,
titanium dioxide,
xanthan gum
Note: Inactive ingredients may vary.
More about amoxicillin / clavulanate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (910)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: penicillins/beta-lactamase inhibitors
- En español
Patient resources
Other brands
Augmentin, Augmentin ES-600, Amoclan, Augmentin XR
Professional resources
- Amoxicillin/Clavulanate monograph
- Amoxicillin and Clavulanate Chewable (FDA)
- Amoxicillin and Clavulanate ER Tablets (FDA)
- Amoxicillin and Clavulanate Oral Suspension (FDA)
- Amoxicillin and Clavulanate Tablets (FDA)
Other brands
Augmentin, Augmentin ES-600, Amoclan, Augmentin XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.